Controlling pyroptosis through post-translational modifications of gasdermin D

Na Zhang1, Daichao Xu2

  • 1Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.

Developmental Cell
|April 8, 2025
PubMed

Insights

Gasdermin D (GSDMD) triggers pyroptosis and inflammation. Post-translational modifications (PTMs) regulate GSDMD activity beyond cleavage, offering insights into inflammatory diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Pyroptosis is a programmed cell death pathway critical for innate immunity and inflammation.
  • Gasdermin D (GSDMD) is a key effector protein mediating pyroptosis by forming membrane pores.
  • Dysregulated pyroptosis contributes to various inflammatory pathologies.

Purpose of the Study:

  • To review the regulatory role of post-translational modifications (PTMs) in controlling Gasdermin D (GSDMD) activity.
  • To explore how PTMs link biological contexts to pyroptosis in innate immunity and inflammation.
  • To highlight potential therapeutic strategies targeting GSDMD regulation for inflammatory conditions.

Main Methods:

  • Literature review of studies investigating Gasdermin D (GSDMD) and its post-translational modifications (PTMs).
  • Analysis of research on the mechanisms by which PTMs modulate GSDMD pore formation and pyroptosis.
  • Synthesis of findings linking PTMs of GSDMD to innate immunity and inflammatory processes.

Main Results:

  • Post-translational modifications (PTMs) represent a crucial layer of regulation for Gasdermin D (GSDMD) activity, independent of proteolytic cleavage.
  • Specific PTMs influence GSDMD oligomerization, membrane insertion, and pore formation, thereby controlling pyroptosis execution.
  • Understanding PTMs of GSDMD provides insights into the fine-tuning of inflammatory responses.

Conclusions:

  • Post-translational modifications (PTMs) are critical regulators of Gasdermin D (GSDMD) function in pyroptosis and inflammation.
  • Targeting GSDMD PTMs offers promising avenues for developing novel therapeutics for inflammatory diseases.
  • Further research into GSDMD PTMs will enhance our understanding of innate immunity and pathology.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K